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Myocarditiscoxsackievirus B3 (CVB3) induces rapid calcium ﬂux in naïve BALB/c CD4+ T cells.
CD4+ cells lacking decay accelerating factor (DAF−/−) show little calcium ﬂux indicating that virus cross-
linking of this virus receptor protein is necessary for calcium signaling in CVB3 infection. Interaction of CVB3
with CD4+ cells also activates NFAT DNA binding. To show that NFAT activation is crucial to CVB3 induced
disease, wild-type mice and transgenic mice expressing dominant-negative NFAT (dnNFAT) mutant in T cells
were infected and evaluated for myocarditis and pancreatitis 7 days later. Inhibition of NFAT in T cells
prevented myocarditis but had no effect on pancreatitis. Virus titers in pancreas were equivalent in wild-type
and dnNFAT animals but cardiac virus titers were increased in dnNFAT mice. Interferon-gamma (IFNγ)
expression was reduced in both CD4+ and Vγ4+ T cells from dnNFAT mice compared to controls. FasL
expression by Vγ4+ cells was also suppressed. Inhibition of FasL expression by Vγ4+ cells is consistent with
myocarditis protection in dnNFAT mice.
© 2008 Elsevier Inc. All rights reserved.Introduction
Enteroviruses, including coxsackie B viruses, are often etiological
agents causing myocarditis and dilated cardiomyopathy (Bowles
et al., 1986; Bowles et al., 2003). Coxsackieviruses are members of
the picornavirus family of small non-enveloped RNA viruses which
replicate in the cell cytoplasm and are usually considered to be
released from infected cells through cell lysis (Rueckert, 1996). As
with nearly all microbial infections, the host response is both
diverse and complex (Fairweather et al., 2001; Gauntt et al., 2000).
Furthermore, host response to the virus, in one form or another,
may be essential to the virus for replication. Studies have found
that coxsackieviruses can only successfully replicate in cells during
the G1/S phase of the cycle due to requirements for virus RNA
translation (Feuer et al., 2003). For only cells already in cycle to be
able to support virus replication would substantially increase the
virus innocula necessary to establish an infection. It is far more
likely that the virus can itself cause cells it binds to enter the cell
cycle and/or become activated. There are several different mechan-
isms by which such activation can occur. These include virus cross-
linking of cellular molecules used as the virus receptor and signal
transduction through this cross-linking (D'Addario et al., 2000;
D'Addario et al., 1999; D'Addario et al., 2001); and signalingtment of Pathology, 208 South
802 656 8965.
l rights reserved.through toll-like receptor (TLR) recognition of viral molecules, most
notably single stranded (ssRNA) and double stranded (dsRNA) viral
RNA (Abreu and Arditi, 2004; Hasan et al., 2005; Lauw, Caffrey, and
Golenbock, 2005; Netea, Van der Meer, and Kullberg, 2004; O'Neill,
2004). Virus-induced cellular activation is also the ﬁrst step in the
host response to the infection since TLR signaling is a potent
inducer of immune cell proliferation and cytokine/chemokine
expression (Rose, 2008; Triantaﬁlou and Triantaﬁlou, 2004). Two
transcription factors are well known to be activated during cox-
sackievirus infections. These are AP-1 and NFkB (Esfandiarei et al.,
2007; Kwon et al., 2004). Activation of these transcription factors is
mediated either through interleukin receptor-associated kinases
(IRAKs) which activate TRAF6 and IKK, or through interferon
response factor 3 and 7 (IRF3 and IRF7). This report is the ﬁrst to
demonstrate a role for NFAT in T cells during coxsackievirus B3
infections.
Results
Coxsackievirus B3 induces calcium ﬂux in lymphocytes through DAF
Enriched CD4+ cells from uninfected BALB/c and DAF−/− mice
were loaded with Indo-1. Calcium ﬂux was initially determined in
unstimulated cells (Fig. 1, basal level), then 4×108 PFU equivalent of
u.v. inactivated H3 virus was added resulting in signiﬁcant increased
calcium ﬂux in the cells in BALB/c cells. Calcium ﬂux was
substantially reduced in DAF−/− cells As a positive control,
ionomycin was added to the cells after measuring calcium ﬂux
induced by the virus.
Fig. 1. Calcium ﬂux on mesenteric lymph node cells. Enriched CD4+ lymphocytes were isolated from naïve BALB/c and BALB/c DAF−/− mice and loaded with Indo-1. Basal levels of
calcium ﬂux were determined on unstimulated cells, then 4×108 PFU equivalent of u.v. inactivated H3 virus was added and calcium ﬂux determination was continued for the time
indicated. As a positive control, ionomycin at a concentration of 250 ng/ml was added to the cells to demonstrate maximum ﬂux.
Fig. 2. H3 virus induces NFAT activation. (A) CD4+ T cells were treated with medium
(M), inactivated H3 (H3) or PMA (5 ng/ml) and ionomycin (250 ng/ml) (PI) for 6 or
12 h. Nuclear extracts were generated and examined by EMSA using an oligo
containing consensus NFAT site. (B) CD4+ T cells were activated for 6 and 12 h with
H3 virus. Nuclear extracts were generated and examined by EMSA for NFAT DNA
binding. Binding reactions were performed in the absence (−) or presence or an anti-
NFATc1 (c1) or anti-NFATc2 (c2) antibodies. (C) CD4+ T cells from BALB/c and BALB/c
DAF−/− mice were activated for 12 h with u.v. inactivated H3 virus, 250 ng/ml
ionomycin (Ion) or 0.1 ml Hela cell extract then nuclear extracts were examined by
EMSA for NFAT binding.
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Calcium ﬂux is critical for the activation of the transcription
factor NFAT. Increased intracellular calcium leads to activation of
the calcium-dependent phosphatase calcineurin which depho-
sphorylates NFAT and promotes its translocation to the nucleus
(Im and Rao, 2004). To determine if the calcium ﬂux induced by
the virus activates NFAT, enriched CD4+ cells from uninfected mice
were cultured for 6 or 12 h in medium, medium containing
4×108 PFU equivalent of u.v. inactivated H3 virus or with 5 ng/ml
PMA and 250 ng/ml ionomycin. Nuclear extracts were obtained
and evaluated by EMSA using an oligo containing a consensus
NFAT binding site (Fig. 2A). Incubation of CD4+ cells with CVB3
was sufﬁcient to induce NFAT DNA binding in these cells.
Conﬁrmation that bands represent NFAT was obtained by super-
shift using anti-NFATc1 and anti-NFATc2 antibodies (Fig. 2B). Since
sucrose puriﬁed virus still contains some HeLa cell proteins,
approximately 107 HeLa cells were washed with PBS, then
alternately frozen and thawed three times. Cell debris was
removed by centrifugation (300 ×g for 10 min) and the supernatant
added to BALB/c T cells for 12 h (Fig. 2C). Additionally, u.v.
inactivated virus was added to BALB/c DAF−/− T cells. Neither virus
added to DAF−/− T cells nor HeLa cell extract added BALB/c T cells
activated NFAT.
NFAT activation promotes induction of myocarditis but not pacreatitis
B10.BR and dnNFAT mice were infected with 105 PFU H3 virus
and killed 7 days later (Figs. 3 and 4). Heart and pancreas were
removed and evaluated for inﬂammation. B10.BR mice develop
signiﬁcant inﬂammation in both heart (Fig. 3, arrow, representative
animal) and pancreas. In contrast, dnNFAT mice develop severe
pancreatitis but little cardiac inﬂammation. Fig. 4 shows cardiac
and pancreatic virus titers (PFU/mg tissue) and shows that dnNFAT
mice have signiﬁcantly more virus in the heart compared to wild-
type B10.BR mice, but pancreatic virus titers are equivalent in both
animals. Mean myocarditis and pancreatitis scores are given for 5–8
mice/group and demonstrate a consistent reduction of myocarditis
but no change in pancreatitis in dnNFAT animals. Differences in
cardiovascular disease was also reﬂected in mean heart:body
weight which was 0.057 for dnNFAT and 0.070 for wild-typemice (pb0.05). Previous studies have shown that FasL and IFNγ
expression in γδ+ cells are required for induction of myocarditis
(Huber et al., 2001; Huber, Shi, and Budd, 2002). Since NFAT
regulates FasL expression (Jayanthi et al., 2005; Ranger et al., 1998),
spleen lymphocytes from infected B10.BR and dnNFAT mice were
labeled with antibodies to Vγ4 and FasL, and intracellularly for
IFNγ (Fig. 5). Total numbers of Vγ4+ cells were slightly, but not
signiﬁcantly elevated in B10.BR mice compared to dnNFAT animals.
However, FasL and IFNγ expression was substantially reduced in
the absence of NFAT expression. Fig. 6 shows representative ﬂow
diagrams of Vγ4+ and CD4+ cells labeled for FasL and IFNγ,
Fig. 3. Hearts and pancreases from B10.BR and dnNFAT B10.BR male mice infected 7 days earlier with 105 PFU H3 virus were formalin ﬁxed, sectioned and stained with hematoxylin
and eosin. Arrow indicates inﬂammation.
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express less IFNγ in dnNFAT mice.
Discussion
This report demonstrates that inactivated CVB3 is capable of
inducing rapid calcium ﬂux in naïve T cells and that the calcium ﬂux is
largely dependent upon the presence of DAF since little ﬂux is
observed in DAF−/− cells. As expected with the amount of calcium ﬂux
observed, NFAT is activated in CD4+ cells by the virus exposure. NFATFig. 4. B10.BR and dnB10.BR mice were infected 7 days earlier with 105 PFU H3 virus.
Heart and pancreas were titered for virus. Data is presented as log10 PFU/mg tissue.
Histology score for inﬂammation. Results are mean±SEM.activation is crucial to myocarditis susceptibility since mice with
impaired activation of NFAT (dnNFAT mice) in T cells fail to develop
myocarditis despite high concentrations of virus in the heart.
Althoughmyocarditis is reduced in infected dnNFATmice, the amount
of pancreatitis and ascinar cell degranulation is unaffected. This
observation strongly indicates that the pathogenic mechanisms for
myocarditis and pancreatitis subsequent to CVB3 infection differ. The
high protease concentrations in the ascinar tissue could lead to auto-
digestion of the tissue with even modest levels of virus induced injury
while most of the myocardial damage is immune mediated (Woodruff
and Woodruff, 1974). This is the ﬁrst report that NFAT is activated
during CVB3 infection.
Two cellular receptors are best known for coxsackieviruses.
These are: decay accelerating factor (DAF, CD55) and coxsackievirus-
adenovirus receptor (CAR). DAF is expressed in non-attached cells
such as leukocytes and may be responsible for the infection and
replication of CVB3 in B cells, dendritic cells and activated T cellsFig. 5. Splenocytes were isolated and labeled with antibodies to Vγ4, FasL and
intracellularly for IFNγ. Cells were evaluated by ﬂow cytometry for percent of splenic
lymphocytes positive for these markers. Data represents the mean±SEM for 5–8
individual mice/group. ⁎ dnNFAT mice signiﬁcantly differ from B10.BR animals at
p≤0.05.
Fig. 6. Flow cytometry on splenic lymphocytes from infected mice. Cells were labeled with antibodies to Vγ4, FasL and CD4. Some cells were intracellularly labeled with antibody to
IFNγ. Numbers in upper right indicate percent of cells in each quadrant.
158 S.A. Huber, M. Rincon / Virology 381 (2008) 155–160(Anderson et al., 1996; Liu et al., 2000). Chimeric fusion proteins
(DAF-Fc and CAR-Fc) are highly effective in inhibiting coxsackievirus
infection in the heart but CAR-Fc alone prevents virus infection of
the pancreas (Goodfellow et al., 2005; Yanagawa et al., 2003;
Yanagawa et al., 2004). Coxsackievirus interactions with both CAR
and DAF lead to optimal infection (Selinka et al., 2004), however,
CAR appears to be the dominant receptor and can lead to infection
with little or no DAF involvement (Pasch et al., 1999). Since DAF is
not involved in CVB3 infection of the pancreas or induction of
pancreatitis, it is reasonable that virus binding to DAF and activation
of NFAT through this pathway would not affect pancreatitis
although inhibition of DAF signal transduction and NFAT activation
in the heart would be pathogenically important. DAF is a GPI
anchored membrane protein, is localized to the lipid raft fraction
and can initiate signal transduction through protein tyrosine kinases
p56lck and p59fyn, early factors in CD3–TCR pathway (Shenoy-
Scaria et al., 1992; Tosello et al., 1998). Antibody cross-linking of GPI
anchored proteins can lead to increased free cytosolic calcium
concentrations (Kroczek et al., 1986) which would be expected to
activate NFAT (Rao, Luo, and Hogan, 1997), which is known to be
dependent on calcium signaling. Thus, it is not surprising that
coxsackieviruses which cross-link DAF could lead to calcium ﬂux
and NFAT activation. NFAT activation regulates expression of multi-
ple genes involved in cell differentiation and proliferation (Hogan et
al., 2003). Many of these genes could impact CVB3 induced
myocarditis. One prime candidate gene controlled by NFAT is FasL
(Jayanthi et al., 2005). Although this communication reports on
virus signaling through DAF in T lymphocytes, other cell types can
also be involved. We have data showing that u.v. inactivated CVB3
effectively binds to endothelial cells (CD31+) derived from the
mouse heart and induces calcium ﬂux similar to that seen in T cells
(data not shown). Thus it is reasonable that this signal transductionpathway could alter protein expression in both cardiocytes and cells
of the immune system.
Coxsackievirus B3 infection dramatically enhances FasL expression
on T cells expressing the γδ T cell receptor (Huber, Shi, and Budd,
2002). Furthermore, previous studies showed that mice lacking either
Fas or FasL fail to develop myocarditis despite normal virus infection
in the heart (Huber, Shi, and Budd, 2002). FasL expression on γδ+ cells
determines susceptibility since adoptive transfer of wild-type (FasL+)
γδ+ T cells into mice lacking FasL (gld/gld) but expressing Fas restores
complete myocarditis susceptibility. In contrast, γδ+ cells lacking FasL
were incapable of inducing myocarditis. Thus, it is highly probable
that a key factor involved in NFAT control of disease susceptibility is
FasL expression on these innate effectors. As shown in this report,
dnNFAT transgenic mice express substantially less FasL than wild-
type animals. Similarly, dnNFAT mice express little IFNγ. While NFAT
does not promote IFNγ expression directly, FasL+γδ+ cells do promote
a Th1 response characterized by CD4+IFNγ+ cells (Huber, Shi, and
Budd, 2002). The mechanism by which γδ+ cells promote the Th1
response is not completely understood, but these effectors are ca-
pable of selectively killing CD4+IL-4 (Th2) cell clones through FasL
dependent pathways (Huber, Sartini, and Exley, 2003). Selective
elimination of Th2 cells could result in enrichment of the remaining
Th1 cells.
Although inactivated virus is capable of activating NFAT, it is not
directly able to induce myocarditis, at least at the equivalent PFU
concentrations (105 PFU) of live virus used to infect mice (personal
observation). Most likely, rapid virus replication of live virus in vivo
substantially increases antigen load resulting in adequate virus
epitope concentration to activate adaptive immunity. These epitope
concentrations would not be achieved using inactivated virus unless
considerably more antigen (microgram) concentrations are used. Also,
live virus signals through Toll-like receptors to activate NFkB as well as
159S.A. Huber, M. Rincon / Virology 381 (2008) 155–160signaling through the virus receptor, DAF, to activate NFAT (Michelsen
et al., 2004). Most likely, lack of any individual mechanism (adequate
antigen processing/presentation, TLR signaling or virus receptor
signaling) would be sufﬁcient to prevent myocarditis.
Materials and methods
Mice
Male BALB/cJ mice were purchased from Jackson Laboratories, Bar
Harbor ME. Male B10.BR and dominant-negative NFAT transgenic
mice on the B10.BR background (Chow, Rincon, and Davis, 1999), were
obtained from Dr. Mercedes Rincon at the University of Vermont.
Decay accelerating factor knockout mice on the BALB/c background
(DAF−/−) were kindly provided by Dr. Wenchao Song, (University of
Pennsylvania, Philadelphia PA) as described previously (Huber, Song,
and Sartini, 2006), and were bred at the University of Vermont. All
mice were 5–7 weeks of age when infected.
Virus
The H3 variant of CVB3wasmade from an infectious cDNA clone as
described previously (Knowlton et al., 1996) and was puriﬁed by
centrifugation through a sucrose cushion (Frolov, Duque, and
Palmenberg, 1999). Virus was grown in HeLa cells until at least 70%
of the cell was detached. The cells and supernatant were frozen and
thawed three times then centrifuged at 10,000 ×g for 30 min. The
supernatant was layered over a cushion of 30% sucrose in 20 mM Tris
(pH 7.4) and 1 M NaCl for 20 h at 13,000 rpm using a GSA rotor in a
Sorvall RC-5B centrifuge (Wilmington, DE).
Infection of mice
Mice were injected intraperitoneally (i.p.) with 105 plaque forming
units (PFU) virus in 0.5ml PBS. Animals were killed whenmoribund or
7 days after infection.
Organ virus titers
Tissue was asceptically removed from the animals, weighed,
homogenized in RPMI 1640 medium containing 5% fetal bovine
serum (FBS), L-glutamine, streptomycin and penicillin. Cellular debris
was removed by centrifugation at 300 ×g for 10 min. Supernatants
were diluted serially using 10-fold dilutions and tittered on Hela cell
monolayers by the plaque forming assay (Van Houten et al., 1991).
Histology
Tissue was ﬁxed in 10% buffered formalin for 48 h, parafﬁn
embedded, sectioned and stained by hematoxylin and eosin.
Calcium ﬂux
Mesenteric lymph node cells were isolated from naïve mice and
pressed through ﬁne mesh screens. CD4+ cells were puriﬁed using
the BD Biosciences CD4+ enrichment kit according to manufacturer's
directions. Purity of the cell population exceeded 90% CD4+ cells.
Cells were washed with RPMI 1640 medium containing 2% FBS and
resuspended to 3×106 cells/ml in medium containing 3 μM Indo-1
(Molecular Probes, Eugene OR) for 45 min at 37 °C. The cells were
washed once, resuspended in medium at 1×106 cells/ml, and
maintained at room temperature. Cells are warmed to 37 °C
5 min before use. A baseline calcium ﬂux is determined on
unstimulated cells using a BD LSR II (BD Immunocytometry, San
Jose CA) equipped with a 355 UV solid state laser (Lightwave
XciteTM), 20 mW. Changes in the concentration of intracellular freeCa2+ ions were measured by monitoring the change in its emission
spectrum from blue to violet upon binding to Ca2+. The blue
emission was measured through a 530/30 BP ﬁlter and the violet
through a 405/20 BP and 405 LP ﬁlter. A shift in the violet/blue ratio
over time is a reﬂection of the increase in the intracellular Ca2+
concentration.
H3 virus was exposed to ultraviolet irradiation for 15 min and
assayed by plaque forming assay to prove the virus was no longer
infectious. Cells were stimulated by adding 4×108 PFU equivalent of
the u.v. inactivated virus. As a positive control, 500 ng/ml ionomycin
(Sigma Chemical Co., St. Louis MO) was added to the same cells after
calcium ﬂux determination with virus.
Electrophoretic mobility shift assay
Nuclear extracts were prepared from stimulated and unstimulated
enriched CD4+ T cells isolated from uninfected BALB/c mice as
previously described (Schreiber et al., 1989; Tugores et al., 1992).
Stimulation was provided by addition of 4×108 PFU equivalent u.v.
inactivated H3 virus or 5 ng/ml PMA and 250 ng/ml ionomycin to the
cells for 6 or 12 h at 37 °C. Binding reactions were performed using
2 μg of nuclear proteins and [32P]dCTP end-labeled double stranded
oligonucleotide probes containing an consensus NFAT binding site
from the proximal IL-4 promoter (Rooney et al., 1994). Samples were
then electrophoresed under nondenaturing conditions and exposed to
ﬁlm for autoradiography. Anti-NFATc1 and anti-NFATc2 antibodies
(Afﬁnity Biocortex) were used (1 μl per reaction) for supershift
experiment.
Intracellular cytokine staining
Details for intracellular cytokine staining have been published
previously (Huber et al., 2001). Spleens were removed and pressed
through ﬁne mesh screens. Lymphoid cells were isolated by
centrifugation of cell suspensions on Histopaque (Sigma). 105 cells
were cultured for 4 h in RPMI 1640 medium containing 10% fetal
bovine serum, 10 μg/ml of Brefeldin A (BFA; Sigma), 50 ng/ml
phorbol myristate acetate (PMA; Sigma), and 500 ng/ml ionomycin
(Sigma). After culture, the cells were washed in PBS-1% bovine serum
albumin (BSA; Sigma) containing BFA, incubated on ice for 30 min in
PBS–BSA–BFA containing a 1:100 dilution of Fc Block, Cy-chrome
conjugated anti-hamster anti-Vγ4 (clone UC3), PE anti-FasL (clone
Kay-10), PE-rat-IgG2 (isotype control; clone R35-95) or Cy-chrome-
hamster IgG (isotype control; clone G235-2356). All antibodies were
from Pharmingen. The cells were washed once with PBS–BSA–BFA,
ﬁxed in 2% paraformaldehyde for 10 min, then resuspended in PBS–
BSA containing 0.5% saponin, Fc Block and 1:100 dilutions of FITC
anti-IFNγ or FITC- and PE-rat IgG1 (clone R3-34) and incubated for
30 min on ice. The cells were washed once in PBS–BSA–saponin and
once in PBS–BSA, the resuspended in 2% paraformaldehyde and
analyzed using a BD LSR II ﬂow cytometer with a single excitation
wavelength (488 nm) and band ﬁlters for Cy-chrome (670 nm), FITC
(525 nm), and PE (575 nm). The cell population was classiﬁed for cell
size (forward scatter) and complexity (side scatter). At least 10,000
cells were evaluated. Positive staining was determined relative to
isotype controls.
Statistics
Differences between groups were determined byWilcoxon Ranked
Score.
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